ArticleClinical and translational science2024

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment.

Rajinder Bhardwaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.